ARTRYA Ltd (AYA) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.122x

Based on the latest financial reports, ARTRYA Ltd (AYA) has a cash flow conversion efficiency ratio of -0.122x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-10.88 Million ≈ $-7.70 Million USD) by net assets (AU$89.35 Million ≈ $63.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ARTRYA Ltd balance sheet independence to measure how much of total assets are equity-financed.

ARTRYA Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how ARTRYA Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore ARTRYA Ltd (AYA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

ARTRYA Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ARTRYA Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Semen Indonesia Persero Tbk
JK:SMGR
0.012x
Vatti Corp Ltd
SHE:002035
0.032x
Phenix Optical Co Ltd
SHG:600071
0.083x
PPC Ltd
JSE:PPC
0.136x
Selamat Sempurna Tbk
JK:SMSM
0.072x
DRI Healthcare Trust
TO:DHT-U
0.053x
Henan Newland Pharmaceutical Co. Ltd. A
SHE:301277
N/A
Shenzhen Textile Holdings Co Ltd
SHE:000045
-0.037x

Annual Cash Flow Conversion Efficiency for ARTRYA Ltd (2019–2025)

The table below shows the annual cash flow conversion efficiency of ARTRYA Ltd from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of ARTRYA Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$21.29 Million
≈ $15.06 Million
AU$-14.27 Million
≈ $-10.10 Million
-0.670x +26.89%
2024-06-30 AU$16.80 Million
≈ $11.89 Million
AU$-15.41 Million
≈ $-10.90 Million
-0.917x -160.90%
2023-06-30 AU$30.56 Million
≈ $21.62 Million
AU$-10.74 Million
≈ $-7.60 Million
-0.351x -48.68%
2022-06-30 AU$40.64 Million
≈ $28.76 Million
AU$-9.61 Million
≈ $-6.80 Million
-0.236x -711.62%
2021-06-30 AU$51.05 Million
≈ $36.12 Million
AU$-1.49 Million
≈ $-1.05 Million
-0.029x +95.53%
2020-06-30 AU$2.49 Million
≈ $1.76 Million
AU$-1.62 Million
≈ $-1.15 Million
-0.651x -478.82%
2019-06-30 AU$852.97K
≈ $603.53K
AU$-95.94K
≈ $-67.89K
-0.112x --

About ARTRYA Ltd

AU:AYA Australia Health Information Services
Market Cap
$593.97 Million
AU$839.46 Million AUD
Market Cap Rank
#11127 Global
#292 in Australia
Share Price
AU$5.24
Change (1 day)
-2.24%
52-Week Range
AU$0.98 - AU$6.27
All Time High
AU$6.27
About

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography sca… Read more